Bardoxolone methyl

CAT: 0804-HY-13324-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-13324-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Bardoxolone (CDDO; RTA 401) methyl is an orally active and brain-penetrant activator of Nrf2 and an inhibitor of SARS-CoV-2 3CL protease. Bardoxolone methyl inhibits SARS-CoV-2 replication in Vero cells with an EC50 value of 0.29 μM. Bardoxolone methyl increases levels of pNrf2 and HO-1, inhibits inflammatory mediators like pNFκB and MCP-1. Bardoxolone methyl activates the Nrf2 pathway to enhance antioxidant and anti-inflammatory responses, inhibits viral replication, and improves mitochondrial function. Bardoxolone methyl can be used in research on chemotherapy-induced neuropathic pain (CINP), COVID-19, and chronic kidney disease (CKD) [1][2][3][4][5].
CAS Number
[218600-53-4]
Product Name Alternative
RTA 402; NSC 713200; CDDO Methyl ester
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
Keap1-Nrf2; SARS-CoV; Virus Protease
Type
Reference compound
Related Pathways
Anti-infection; NF-κB
Applications
Cancer-programmed cell death
Field of Research
Infection; Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/Bardoxolone-methyl.html
Purity
99.66
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C1C(C#N)=C[C@@]2(C)[C@](CC[C@]([C@@]3(C)[C@@]4([H])[C@@]5([H])[C@@](CCC(C)(C)C5)(C(OC)=O)CC3)(C)C2=CC4=O)([H])C1(C)C
Molecular Formula
C32H43NO4
Molecular Weight
505.69
Precautions
H302, H315, H319, H335
References & Citations
[1]Reisman SA, et al. Bardoxolone Methyl Decreases Megalin and Activates Nrf2 in the Kidney. J Am Soc Nephrol. 2012 Aug 2.|[2]McCullough PA, et al. Cardiac and renal function in patients with type 2 diabetes who have chronic kidney disease: potential effects of bardoxolone methyl. Drug Des Devel Ther. 2012;6:141-9.|[3]Yasemin Teksen, et al. Bardoxolone methyl attenuates acetaminophen-induced acute kidney injury by suppressing oxidative stress, inflammation and apoptosis[J]. 2024 May 29;31 (5) :372–379|[4]Kim HK, et al. Bardoxolone Methyl Ameliorates Chemotherapy-Induced Neuropathic Pain by Activation of Phosphorylated Nuclear Factor Erythroid 2-Related Factor 2 in the Dorsal Root Ganglia. Anesth Analg. 2024 Mar 1;138 (3) :664-675.|[5]Sun Q, et al. Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease. Signal Transduct Target Ther. 2021 May 29;6 (1) :212.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched

Related Products

CatalogName
HY-14909-01Bardoxolone
HY-14909R-01Bardoxolone (Standard)
HY-152650N6-Methyl-2-methyl thioadenosine
HY-134716Methyl acetate-PEG1-methyl acetate
HY-W722239Methyl 2- (methyl-d3) butanoate
HY-145998-012′-O-Methyl-8-methyl guanosine
HY-152693-01N4-Methyl-2’-O-methyl-cytidine
HY-166007Methyl 11-methyl-12 (E) -octadecenoate
HY-152611N1-Methyl-5-methyl ara-uridine
HY-W100234-015-Methyl-2′-O-methyl-uridine

Alternative Products

CatalogName
OR1025712-01Bardoxolone Methyl
A11323-50Bardoxolone methyl 50mg
A11323-25Bardoxolone methyl 25mg
A11323-200Bardoxolone methyl 200mg
A11323-100Bardoxolone methyl 100mg
MBS385825-01Bardoxolone methyl (RTA 402)
MBS132043-01Bardoxolone methyl RTA 402
A11323-5Bardoxolone methyl (RTA 402) 5mg
A11323-10Bardoxolone methyl (RTA 402) 10mg
A11323-500Bardoxolone methyl (RTA 402) 500mg

Popular Products